FINANCIAL SUMMARY Third quarter, 1 July – 30 September 2020 The Redsense Group · Net sales amounted to KSEK 2,107 (4,645), a 55 percent decrease compared with the corresponding period in 2019. · Profit or loss before tax amounted to KSEK -3,723 (-590). The Swedish Parent Company · Net sales amounted to KSEK 1,595 (3,257).…
Read moreFINANCIAL SUMMARY Second quarter, 1 April – 30 June 2020 The Redsense Medical Group • Net sales amounted to kSEK 5,292 (2,758), a 92 percent increase compared with the corresponding period in 2019. • Profit or loss before tax amounted to kSEK 93 (-1,388). The Swedish Parent Company • Net sales amounted to kSEK 3,946 (2,060).…
Read moreFINANCIAL SUMMARY First quarter, 1 Januari – 31 Mars 2020 The Group · Net sales amounted to kSEK 4,996 (1,964), a 154 percent increase compared with the corresponding period in 2019. · Earnings before tax amounted to kSEK 241 (-706). · Total equity amounted to kSEK 14,947 at the end of the period. · Available…
Read moreFULL YEAR, 1 JANUARY – 31 DECEMBER 2019 The Group • Total operating income for the financial year amounted to kSEK 13,863 (8,702). • Net sales for the financial year amounted to kSEK 13,265 (7,006). • Operating result (EBIT) amounted to kSEK -3,742 (-6,829). • Total equity amounted to kSEK 8,694 at the end of…
Read moreQuarter 3, 2019, showed an increase in sales of 103% versus same period last year and is the strongest in the company’s history. The growth is driven by the US market.
Read moreThe strongest result in the company’s history The first half of 2019 is the strongest yet in the company’s history, with an increase of 30% versus same period last year. Q2 was up 12% versus same period last year and is the strongest quarter on record for the company and we can already now estimate…
Read more